Page 901 - Robbins Basic Pathology by Vinay Kumar, Abul K. Abbas, Jon C. Aster
P. 901
Hippel-Lindau syndrome 257–258 Index 887
infant hemangiomas and 257–258
Humoral rejection, acute 137f, 138
Hirschsprung disease Hunter syndrome. See Mucopolysaccharidosis (MPS)
as intestinal obstruction 573–574 Huntington disease (HD)
morphology of 574b, 574f
pathogenesis of 574b morphology of 840b, 840f
neurodegenerative diseases and 840
Histamine 46 pathogenesis of 840b
Histiocytic neoplasm 449 Hurler syndrome. See Mucopolysaccharidosis (MPS)
Histiocytoma, benign fibrous 794 Hyaline membrane disease. See Respiratory distress syndrome
Histoplasmosis (RDS)
Hyaluronan 64
clinical features of 499–500 Hydatid cyst 314
epidemiology of 499–500 Hydatidiform mole
morphology of 499b, 500f as gestational trophoblastic disease 701–702, 702t
as pulmonary infection 499–500 morphology of 702b, 702f
HIV. See Human immunodeficiency virus (HIV) summary for 703b
HLA. See Human leukocyte antigen (HLA) Hydrocephalus 812–813, 813f
Hodgkin lymphoma summary for 814b
classification of 440–442 Hydronephrosis
as lymphoid neoplasm 440–442 clinical course of 546–547
morphology of 440b–441b, 440f morphology of 546b, 546f
pathogenesis of 441b–442b pathogenesis of 546b
staging and clinical features of 442, 442t and urinary outflow obstruction 545–547
summary for 444 Hydrops, nonimmune 255–257
Hodgkin lymphoma, lymphocyte-predominance 441, Hydrops fetalis 254, 255f, 256b, 257
441f Hydrostatic pressure 77, 77f
Hodgkin lymphoma, nodular sclerosis 440, 440f–441f Hyperadrenalism. See Adrenocortical hyperfunction
Holoprosencephaly 247–248 Hyperaldosteronism
Homologous recombination, DNA repair and 197 and adrenocortical hyperfunction 755–756
Homozygous 183 clinical features of 756
Host immune response 321–322 morphology of 755b–756b
Human anti-globulin test (Coombs test) 256–257 Hypercholesterolemia 336–337
Human immunodeficiency virus (HIV). See also Acquired Hypercholesterolemia, familial
immunodeficiency syndrome (AIDS) gene encoding mutations and 222–223
B cells and other lymphocytes in 149 pathogenesis of 222b–223b
dendric cells and 149 summary for 223b
etiology/pathogenesis of AIDS and 144–149 Hypercoagulability 87–88, 87t
heroin and 286 Hypercortisolism. See also Cushing syndrome
life cycle of 145–146, 146f and adrenocortical hyperfunction 752–755, 753f
mechanisms of T cell depletion in 147–148, 148f, 150 summary for 755b
monocytes/macrophages in 148–149 Hyperemia 75
morphology of 152b morphology of 75b–76b, 76f
natural history/clinical course for 150–153, 150f Hyperglycemia 835
Hyperhomocysteinemia 337–338
acute phase of 150 Hyper-IgM syndrome 141, 143
chronic phase of 150 Hyperlipidemia 336–337
clinical features of 151–153, 151t Hyperparathyroidism
crises phase of 150–151 acquired bone disease as 771
neoplasms and 151–152 clinical features of 737–738, 737t
opportunistic infections and 151 morphology of 736b–737b, 736f–737f, 772b, 772f
nervous system infections and 828, 832 and parathyroid glands 735–738
morphology of 827f, 828b pathogenesis of 736b
pathogenesis of CNS involvement for 149 secondary hyperparathyroidism and 738
progression of infection and 146–147, 147f, 147t summary for 738b
pulmonary infections in 504 Hyperparathyroidism, secondary
structure of 144–145, 145f clinical features of 738
summary for 149b–150b introduction to 738
Human leukocyte antigen (HLA) morphology of 738b
adoptive immunity and 102, 124t summary for 738
genetic factors of SLE and 126 Hyperpituitarism
graft survival and 138 and the pituitary gland 717–720
GVHD and 139
Human leukocyte antigen allele, polymorphisms and 234 (See also Pituitary adenoma)
Human papillomavirus (HPV) 202 summary for 719b
Human papillomavirus (HPV) infection Hyperplasia
morphology of 678b as adaptive response 1–2
sexually transmitted disease and 678 hypertrophy and 3
summary for 678b–679b stress and 4
Humoral immunity 100, 108f summary for 5b
as antitumor effector mechanism 206–207 vitamin A and 298